BACKGROUND: We examined the relationship between maternal plasma lipoprotein and antioxidant status with risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. METHODS: One hundred seventy-three pregnant women with preeclampsia and 186 controls were included in a case-control study. Maternal plasma total cholesterol, high-density lipoprotein (HDL), and total triglycerides were measured using enzymatic methods. Plasma carotenoids (alpha-carotene, beta-carotene, lycopene, lutein, beta-cryptoxanthin, zeaxanthin), retinol, and tocopherols (alpha-tocopherol and gamma-tocopherol) were determined using high performance liquid chromatography. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Preeclampsia risk increased with successively higher quartiles of plasma triglyceride (OR: 1.00, 1.70, 2.00, 5.26, with the lowest quartile as referent; P for trend <.001). We noted an inverse association between preeclampsia risk and HDL cholesterol concentrations (OR: 1.00, 0.87, 0.66, 0.68, with the first quartile as the referent group; P for trend =.169), although the trend was not statistically significant. After adjusting for confounders, we noted decreases in preeclampsia risk with increasing concentrations of alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, and zeaxanthin, respectively. Women with beta-carotene concentrations in the highest quartile, as compared with those in the lowest quartile experienced a 50% decreased risk of preeclampsia (OR = 0.50, 95% CI 0.25-1.00). There was no clear pattern of preeclampsia risk with lycopene concentrations or with concentrations of gamma- and alpha-tocopherol. CONCLUSIONS: Our results are consistent with some, although not all, previous reports. Prospective studies are needed to determine the temporal relationship between observed alterations in lipid and antioxidant concentrations in preeclamptic pregnancies.
BACKGROUND: We examined the relationship between maternal plasma lipoprotein and antioxidant status with risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. METHODS: One hundred seventy-three pregnant women with preeclampsia and 186 controls were included in a case-control study. Maternal plasma total cholesterol, high-density lipoprotein (HDL), and total triglycerides were measured using enzymatic methods. Plasma carotenoids (alpha-carotene, beta-carotene, lycopene, lutein, beta-cryptoxanthin, zeaxanthin), retinol, and tocopherols (alpha-tocopherol and gamma-tocopherol) were determined using high performance liquid chromatography. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Preeclampsia risk increased with successively higher quartiles of plasma triglyceride (OR: 1.00, 1.70, 2.00, 5.26, with the lowest quartile as referent; P for trend <.001). We noted an inverse association between preeclampsia risk and HDL cholesterol concentrations (OR: 1.00, 0.87, 0.66, 0.68, with the first quartile as the referent group; P for trend =.169), although the trend was not statistically significant. After adjusting for confounders, we noted decreases in preeclampsia risk with increasing concentrations of alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, and zeaxanthin, respectively. Women with beta-carotene concentrations in the highest quartile, as compared with those in the lowest quartile experienced a 50% decreased risk of preeclampsia (OR = 0.50, 95% CI 0.25-1.00). There was no clear pattern of preeclampsia risk with lycopene concentrations or with concentrations of gamma- and alpha-tocopherol. CONCLUSIONS: Our results are consistent with some, although not all, previous reports. Prospective studies are needed to determine the temporal relationship between observed alterations in lipid and antioxidant concentrations in preeclamptic pregnancies.
Authors: Lewis P Rubin; A Catharine Ross; Charles B Stephensen; Torsten Bohn; Sherry A Tanumihardjo Journal: Adv Nutr Date: 2017-03-15 Impact factor: 8.701
Authors: K Sathishkumar; M Balakrishnan; V Chinnathambi; M Chauhan; G D V Hankins; C Yallampalli Journal: J Perinatol Date: 2011-09-08 Impact factor: 2.521
Authors: Eileen R Fowles; Lorraine O Walker; C Nathan Marti; Roberta Jeanne Ruiz; Joel Wommack; Miranda Bryant; Sunghun Kim; Gayle M Timmerman Journal: Arch Gynecol Obstet Date: 2012-01-11 Impact factor: 2.344
Authors: Alejandra Perez-Sepulveda; Pedro P España-Perrot; Errol R Norwitz; Sebastián E Illanes Journal: Reprod Sci Date: 2013-03-01 Impact factor: 3.060
Authors: Madona Azar; Arpita Basu; Alicia J Jenkins; Alison J Nankervis; Kristian F Hanssen; Hanne Scholz; Tore Henriksen; Satish K Garg; Samar M Hammad; James A Scardo; Christopher E Aston; Timothy J Lyons Journal: Diabetes Care Date: 2011-04-15 Impact factor: 19.112
Authors: Jean M Kerver; Claudia B Holzman; Yan Tian; Bertha L Bullen; Rhobert W Evans; Jamil B Scott Journal: J Womens Health (Larchmt) Date: 2021-02-17 Impact factor: 3.017
Authors: Jacqueline M Cohen; Margaret Beddaoui; Michael S Kramer; Robert W Platt; Olga Basso; Susan R Kahn Journal: PLoS One Date: 2015-08-06 Impact factor: 3.240
Authors: Amar S More; Jay S Mishra; Kathirvel Gopalakrishnan; Chellakkan S Blesson; Gary D Hankins; Kunju Sathishkumar Journal: Biol Reprod Date: 2015-11-19 Impact factor: 4.285